Empresa Celsion Corporation Nasdaq
Acciones
US15117N3052
Biotecnología e investigación médica
Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
|
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Stacy Lindborg
CEO | Chief Executive Officer | 53 | 04/06/21 |
Michael Tardugno
CHM | Chairman | 73 | 03/01/07 |
Sebastien Hazard
CTO | Chief Tech/Sci/R&D Officer | 53 | 11/12 |
Khursheed Anwer
CTO | Chief Tech/Sci/R&D Officer | 64 | 20/06/14 |
Kimberly Bragg
AUD | Comptroller/Controller/Auditor | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 56 | 08/06/21 | |
Frederick Fritz
BRD | Director/Board Member | 73 | 08/07/11 |
James Dentzer
BRD | Director/Board Member | 57 | 03/09/22 |
Michael Tardugno
CHM | Chairman | 73 | 03/01/07 |
Donald Braun
BRD | Director/Board Member | 74 | 15/12/15 |
Stacy Lindborg
CEO | Chief Executive Officer | 53 | 04/06/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 9 400 911 | 9 292 541 ( 98,85 %) | 22 ( 0,000234 %) | 98,85 % |
Información de la empresa
![Dirección Celsion Corporation](https://cdn.zonebourse.com/static/address/897284.png)
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+20,17 % | 127 mil M | |
+24,67 % | 117 mil M | |
+25,44 % | 27,67 mil M | |
-17,74 % | 20,33 mil M | |
-15,17 % | 16,79 mil M | |
-15,21 % | 15,63 mil M | |
+11,91 % | 14,84 mil M | |
-47,10 % | 14,65 mil M | |
+54,50 % | 14,43 mil M |
- Bolsa de valores
- Acciones
- Acción IMNN
- Acción
- Empresa Celsion Corporation